As of 2024-09-19, the Relative Valuation of Novavax Inc (NVAX) is (72.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.56 USD, the upside of Novavax Inc based on Relative Valuation is -676.4%.
The range of the Relative Valuation is (61.89) - (66.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.7x - 59.8x | 46.4x |
| Forward P/E multiples | 28.5x - 36.0x | 32.3x |
| Fair Price | (61.89) - (66.27) | (72.40) |
| Upside | -592.8% - -627.6% | -676.4% |
| Date | P/E |
| 2024-09-18 | -6.83 |
| 2024-09-17 | -7.03 |
| 2024-09-16 | -7.18 |
| 2024-09-13 | -7.40 |
| 2024-09-12 | -6.48 |
| 2024-09-11 | -6.68 |
| 2024-09-10 | -6.91 |
| 2024-09-09 | -6.95 |
| 2024-09-06 | -6.33 |
| 2024-09-05 | -6.50 |
| 2024-09-04 | -6.46 |
| 2024-09-03 | -6.89 |
| 2024-08-30 | -6.73 |
| 2024-08-29 | -6.20 |
| 2024-08-28 | -6.05 |
| 2024-08-27 | -6.06 |
| 2024-08-26 | -6.26 |
| 2024-08-23 | -6.52 |
| 2024-08-22 | -6.50 |
| 2024-08-21 | -7.04 |
| 2024-08-20 | -7.08 |
| 2024-08-19 | -7.56 |
| 2024-08-16 | -7.05 |
| 2024-08-15 | -6.87 |
| 2024-08-14 | -6.63 |
| 2024-08-13 | -6.61 |
| 2024-08-12 | -6.44 |
| 2024-08-09 | -6.31 |
| 2024-08-08 | -6.35 |
| 2024-08-07 | -5.82 |
| 2024-08-06 | -6.27 |
| 2024-08-05 | -6.19 |
| 2024-08-02 | -6.41 |
| 2024-08-01 | -6.84 |
| 2024-07-31 | -6.97 |
| 2024-07-30 | -6.64 |
| 2024-07-29 | -8.93 |
| 2024-07-26 | -9.31 |
| 2024-07-25 | -9.07 |
| 2024-07-24 | -8.38 |
| 2024-07-23 | -8.91 |
| 2024-07-22 | -8.13 |
| 2024-07-19 | -7.53 |
| 2024-07-18 | -8.14 |
| 2024-07-17 | -8.62 |
| 2024-07-16 | -8.94 |
| 2024-07-15 | -8.22 |
| 2024-07-12 | -7.13 |
| 2024-07-11 | -7.05 |
| 2024-07-10 | -6.49 |